资源描述：
《复方丹参滴丸在老年慢性阻塞性肺疾病缓解期中的应用效果观察.doc》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、复方丹参滴丸在老年慢性阻塞性肺疾病缓解期中的应用效果观察［摘要］目的探讨复方丹参滴丸在老年慢性阻塞性肺疾病缓解期治疗中的应用效果。方法选取2010年5月〜2013年5月来木院就诊的59例老年慢性阻塞性肺疾病缓解期患者，随机分为观察组29例及对照组30例，对照组采用阿莫西林分散片治疗，观察组采用复方丹参滴丸治疗；观察两组患者的临床治疗效果、不良反应发生率及治疗前后Q0L评分情况。结果观察组总有效率为93.10%,对照组为76.67%,差异有统计学意义(P<0.05)o观察组不良反应发生率为10.35%,对照组为30.
2、00%,差异有统计学意义(PV0.05)。观察组治疗后Q0L评分(良好率+较好率)明显高于对照组，差异有统计学意义(P<0.05)o结论复方丹参滴丸治疗老年慢性阻塞性肺疾病缓解期的效果显著，可明显降低不良反应的发生率。［关键词］复方丹参滴丸；老年；慢性阻塞性肺疾病；缓解期；治疗［中图分类号］R563［文献标识码］A［文章编号］1674-4721(2014)05(a)-0036-03ObservationonapplicationeffectofcompoundDanshendrippingpillsinthetre
3、atmentofsenilechronicobstructivepulmonarydiseaseduringremissionperiodZENGZhiDepartmentofGeriatrics,HospitalofTraditionalChineseMedicineinShaoguanCityofGuangdongProvince,Shaoguan512026,China[Abstract]ObjectiveToexploretheapplicationeffectsofcompoundDanshendripp
4、ingpillsinthetreatmentofsenilechronicobstructivepulmonarydiseaseduringremissionperiod・Methods59elderlypatientswithchronicobstructivepulmonarydiseaseduringremissionperiodinourhospitalfromMay2010toMay2013wererandomlydividedintotheobservationgroupof29casesandthec
5、ontrolgroupof30cases.Thecontrolgroupwastreatedwithamoxicillindispersibletabletstreatment,theobservationgroupwastreatedwithcompoundDanshendrippingpills.Thetreatment,effectandincidenceofadversereactionofpatientsinthetwogroupswereanalyzed,andtheQOLscoreofpatients
6、beforeandaftertreatmentwereallcompared.ResultsThetotaleffectiverateofobservationgroupwas93.10%,thecontrolgroupwas76.67%,thedifferencewasstatisticallysignificant,betweenthetwogroups(卩〈0.05)•Theincidenceofadversereactionoftheobservationgroupwas10.35%,thecontrolg
7、roupwas30%,thedifferencewasstatisticallysignificantbetweenthetwogroups(P<0.05).TheQOLscore(goodrateandbetterrate)aftertreatmentintheobservationgroupwassignificanllyhigherthanlhatinthecontrolgroup,thedifferencewasstatisticallysignificant(P<0.05).ConclusionTheco
8、mpoundDanshendrippingpillsinthetreatmentofelderlypatientswithchronicobstruetivepulinonarydiseaseduringremissionperiodhasobviouseffect,lowincidenceofsideeffects,andisworthyofclinica
